Accelerate Diagnostics, Inc. (AXDX) financial statements (2023 and earlier)

Company profile

Business Address 3950 S. COUNTRY CLUB ROAD #470
TUCSON, AZ 85714
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments40,69836,18161,01466,26028,51319,244120,585
Cash and cash equivalents39,89835,78161,01466,26028,51319,244120,585
Short-term investments800400     
Receivables2,3201,5503,2221,8601,9463477
Inventory, net of allowances, customer advances and progress billings5,0679,2168,0597,7468,063  
Inventory5,0679,2168,0597,7468,063  
Prepaid expense7681,172955980   
Other current assets1,5581,7801,16557646818312
Other undisclosed current assets22,92032,08847,437100,21881,49858,98713,477
Total current assets:73,33181,987121,852177,640120,48878,448134,151
Noncurrent Assets
Operating lease, right-of-use asset2,5103,1833,917
Property, plant and equipment5,3896,1357,9057,3034,8904,2585,016
Intangible assets, net (including goodwill)   114134146157
Intangible assets, net (excluding goodwill)   114134146157
Other noncurrent assets1,8172,120750208   
Total noncurrent assets:9,71611,43812,5727,6255,0244,4045,173
TOTAL ASSETS:83,04793,425134,424185,265125,51282,852139,324
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,7455,5437,4417,5463,6363,0092,543
Accounts payable1,9831,2902,3511,3222,0809922,623
Accrued liabilities2,8532,9913,8284,962   
Interest and dividends payable9091,2621,2621,262   
Other undisclosed accounts payable and accrued liabilities    1,5562,017(80)
Deferred revenue451376271
Debt80553450    
Deferred revenue and credits  13
Contract with customer, liability217
Other undisclosed current liabilities669497  3,1511,0272,750
Total current liabilities:6,9456,9698,1627,7636,7874,0365,306
Noncurrent Liabilities
Long-term debt and lease obligation110,3657,722133,622120,074   
Long-term debt, excluding current maturities107,9844,659130,043120,074   
Operating lease, liability2,3813,0633,579
Liabilities, other than long-term debt8083351953211,0001,000
Deferred revenue and credits 1,0001,000
Other liabilities808335195321  
Other undisclosed noncurrent liabilities 141,211     
Total noncurrent liabilities:111,173149,268133,641120,127211,0001,000
Total liabilities:118,118156,237141,803127,8906,8085,0366,306
Stockholders' equity
Stockholders' equity attributable to parent, including:(35,071)(62,812)(7,379)57,375118,70477,816133,018
Preferred stock4      
Treasury stock, value(45,067)(45,067)(45,067)(45,067)   
Additional paid in capital580,652475,072452,344432,885360,620255,257243,894
Accumulated other comprehensive income (loss)(60)91(58)(149) (204)(12)
Accumulated deficit(570,668)(492,966)(414,653)(330,348)(241,972)(177,289)(110,915)
Other undisclosed stockholders' equity attributable to parent68585554565251
Total stockholders' equity:(35,071)(62,812)(7,379)57,375118,70477,816133,018
TOTAL LIABILITIES AND EQUITY:83,04793,425134,424185,265125,51282,852139,324

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues11,78211,1659,2975,6704,177246147
Revenue, net4,177246147
Cost of revenue(12,163)(6,706)(4,897)(3,187)(1,002)(2,294)(1,759)
Cost of goods and services sold(12,163)(6,706)(4,897)(3,187)(1,002)  
Gross profit:(381)4,4594,4002,4833,175(2,048)(1,612)
Operating expenses(71,179)(68,159)(77,231)(82,852)(67,359)(64,453)(43,937)
Operating loss:(71,560)(63,700)(72,831)(80,369)(64,184)(66,501)(45,549)
Nonoperating income (expense)(6,097)(14,602)(11,158)(7,125)32339451
Investment income, nonoperating (99)427621(326)  
Other nonoperating income (expense)(6,097)(14,503)(11,585)(7,746)64939451
Interest and debt expense9,793(15,457)(600)(399)  (4)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 15,556173(222)326 4
Loss from continuing operations before equity method investments, income taxes:(67,864)(78,203)(84,416)(88,115)(63,535)(66,107)(45,498)
Other undisclosed loss from continuing operations before income taxes(9,793)      
Loss from continuing operations before income taxes:(77,657)(78,203)(84,416)(88,115)(63,535)(66,107)(45,498)
Income tax expense (benefit)(45)(5)111(211)(493)(267) 
Net loss available to common stockholders, diluted:(77,702)(78,208)(84,305)(88,326)(64,028)(66,374)(45,498)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(77,702)(78,208)(84,305)(88,326)(64,028)(66,374)(45,498)
Comprehensive loss:(77,702)(78,208)(84,305)(88,326)(64,028)(66,374)(45,498)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(151)14991(149)204(192)(19)
Comprehensive loss, net of tax, attributable to parent:(77,853)(78,059)(84,214)(88,475)(63,824)(66,566)(45,517)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: